Digital Rectal Exam Has Low Diagnostic Value for Prostate Cancer

Follow Drugslib on

Medically reviewed by Drugs.com.

By Elana Gotkine HealthDay Reporter

FRIDAY, Jan. 26, 2024 -- Digital rectal examination (DRE) exhibits low diagnostic value as an independent test and supplementary measure to prostate-specific antigen (PSA) for detection of prostate cancer, according to a study published online Jan. 4 in European Urology Oncology.

Akihiro Matsukawa, from the Medical University of Vienna in Austria, and colleagues identified prospective studies simultaneously investigating the diagnostic performance of DRE and PSA for prostate cancer screening to assess the diagnostic value of DRE for early detection of prostate cancer. The positive predictive value (PPV) and cancer detection rate (CDR) of DRE were examined as primary end points.

Eight studies, including three randomized controlled trials and five prospective diagnostic studies, with 85,738 participants were identified, which reported PPV and CDR of both DRE and PSA for the same cohort. The researchers found that the pooled PPV was 0.21 for DRE, which was similar to the PPV of PSA (0.22), with no additional benefit for combining DRE and PSA (0.19). The CDR was significantly lower for DRE than PSA and the combination of DRE and PSA (0.01 versus 0.03 and 0.03, respectively). In terms of CDR and PPV, combining DRE and PSA was not significantly different to PSA alone.

"These findings suggest that DRE could be potentially omitted from prostate cancer screening and early detection in the absence of clinical symptoms and signs," the authors write.

Several authors disclosed ties to the pharmaceutical industry.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-01-27 02:15

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords